ELIMINATE 
ALL 
PREVENTABLE 
BLINDNESS


Patients may suffer from serious eye diseases or blindness 

due to the lack of timely eye exams. 

We aim to utilize platforms and AI technology 

to provide solutions, actively preventing and treating eye diseases 

to reduce blindness.

 

 


Vision & Mission

Eliminate
All Preventable Blindness

Not Inevitable.

Diabetic retinopathy can threaten sight



Diabetic retinopathy can threaten sight—but vision loss is not inevitable. Regular eye examinations and timely treatment can help reduce avoidable vision loss.

Evidence-Based.

Backed by leading medical guidance



Medical sources: WHO, U.S. National Eye Institute, and Korea Disease Control and Prevention Agency. Evidence checked 2026-08-01. 

20%

undergo regular screenings




However, fewer than 20% of people living with diabetes actually receive the necessary tests.

Our vision is to contribute to a reduction
in the number of people worldwide suffering from blindness 
by encouraging those living with this commonly underestimated chronic disease -
diabetes, to more readily engage in health checks and
to take proactive measures to preserve their eye health.

What we do

Cutting-edge technology at my fingertips, my eye health managed from my own hand.

A significant array of technologies, including artificial intelligence, are already aiding medical professionals in various fields, including ophthalmology. We believe these technologies will continue to evolve and benefit an increasing number of patients. However, our focus is not solely on the faith in the technology, but rather on creating services that can be actively utilized by patients and medical staff in clinical settings and widely disseminated across numerous medical fields.

FOR MORE INFORMATION
About

Top-tier entrepreneurs in digital healthcare, ophthalmology specialists
with decades of experience, and serial entrepreneurs with public listing experience
in the medical field have joined forces.

Co-CEO

Sang Jun Park

Associate Professor, Retina Specialist

Department of Ophthalmology, 

Seoul National University 
Bundang Hospital

  • Advisor, Kakao Healthcare 
  • Academic Director and Planning Director, Korean Society for Medical Artificial Intelligence 
  • Committee Member, Guidelines for AI Medical Devices, Ministry of Food and Drug Safety 
  • Expert Committee Member, Medical Device Committee, Ministry of Food and Drug Safety 
  • Advisory Committee Member, Korea Health Industry Development Institute 
  • Practical Professor, Big Data Center, Seoul National University Bundang Hospital 
  • Editorial Board Member, Ophthalmic Epidemiology 
  • Editorial Board Member, Journal of Retina


Co-CEO

Hyun-Jun Kim

Co-founder and CEO, VUNO Inc. 
(Listed on KOSDAQ,2021)


  • Subdivision Chief of Digital Healthcare, Strategic Division of Medical Devices, Ministry of Health and Welfare 
  • Adjunct Professor, Medical Device MBA, Dongguk University 
  • Advisory Committee Member, Korea Medical Devices Industrial Cooperative Association 
  • Policy Committee Member, Digital Healthcare, Korea Venture Business Association 
  • Science and Technology Committee Member, Presidential Committee for the Fourth Industrial Revolution 
  • Committee Member, Guidelines for AI Medical Devices, Ministry of Food and Drug Safety 
  • Senior Researcher, Samsung Advanced Institute of Technology
  • Founder and CEO, VYTE Inc. 

We have attracted investment from some of the top technology-based early-stage investors in South Korea and have also been selected for the nation's premier startup program.

News
SEE MORE
Contact

We welcome contact from anyone,
anywhere in the world,
who is interested in our mission 
and philosophy.

HQ: Cell 7A, Maru360, 172 Yeoksam-ro, Gangnam-gu, Seoul (06248)
R&D Center: Room #4, Startup Incubation Center 2F, 172 Dolma-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Healthcare Innovation Park, Seoul National University Bundang Hospital (13605)

+82-31-711-5550

hello@clop.ai